Related Experiment Video
Updated: Jun 29, 2026

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
Published on: September 9, 2011
Percutaneous VA-ECMO from Cannulation to Decannulation: Novel Use of a Vascular Closure Device in Pediatrics
Ernesto Mejia1, Elaina Cummer1, Gareth J Morgan1
1The Heart Center, Children's Hospital Colorado, University of Colorado, 13123 E 16th Ave, B100, Aurora, CO, 80045, USA.
Insights
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) decannulation in pediatric patients can be safely achieved using the MANTA vascular closure device. This approach avoids surgical repair, reducing risks associated with VA-ECMO removal.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Medical Device Technology
Background:
- Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a critical intervention for pediatric cardiogenic shock.
- Decannulation from VA-ECMO typically requires surgical vascular repair, which carries inherent risks.
- Minimally invasive techniques for vascular closure are sought to improve patient outcomes.
Purpose of the Study:
- To evaluate the safety and efficacy of the MANTA vascular closure device for percutaneous VA-ECMO decannulation in pediatric patients.
- To compare outcomes of MANTA device closure with traditional surgical repair for VA-ECMO access sites.
Main Methods:
- A retrospective case series of eight pediatric patients undergoing VA-ECMO decannulation.
- Utilized the MANTA collagen plug-based vascular closure device for common femoral artery access site closure.
- Documented procedural success, decannulation time, and access site-related complications.
Main Results:
- Seven out of eight patients (87.5%) were successfully decannulated without access site-related vascular complications using the MANTA device.
- One patient experienced device failure requiring conversion to surgical cut-down and arterial repair.
- No major bleeding events or pseudoaneurysms were reported in the successfully treated patients.
Conclusions:
- The MANTA vascular closure device represents a viable option for percutaneous VA-ECMO decannulation in the pediatric population.
- This technique may reduce the need for surgical intervention and associated complications.
- Careful patient selection and operator experience are crucial for optimizing success rates and mitigating potential technical challenges.
Abstract:
VA-ECMO can be lifesaving in cardiogenic shock in children. While surgical vascular repair is the current standard of care for decannulation, it comes with notable risks. We present a series of eight patients who underwent decannulation with a collagen plug-based vascular closure device (MANTA) for the common femoral artery. Seven of the patients were successfully decannulated without access site-related vascular complications. One required conversion to surgical cut-down with arterial repair due to device failure. This series demonstrates the successful use of the MANTA device in percutaneous VA-ECMO decannulation in the pediatric population, while highlighting potential technical challenges for success.
Related Concept Videos
Tracheostomy Decannulation
Description of the Procedure
Decannulation refers to the permanent removal of the tracheostomy tube, signaling the resolution of the condition that initially necessitated the tracheostomy. The process requires a well-coordinated interplay between...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)

